Citations (169)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Guangyao Huang, Liang Yang, Zhaoyan Zhang, Sijia Ren, Xianglin Tang, Wei Zhou, Yuguang Wang, Zengchun Ma, Shan Gao & Yue Gao. (2019) Human PXR-mediated transcriptional activation of CYP3A4 by ‘Fuzi’ extracts. Toxicology Mechanisms and Methods 29:3, pages 155-164.
Read now
Read now
Lucy Chen & G V Ramesh Prasad. (2018) CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment. Pharmacogenomics and Personalized Medicine 11, pages 23-33.
Read now
Read now
Tingdong Yu, Xiangkun Wang, Guangzhi Zhu, Chuangye Han, Hao Su, Xiwen Liao, Chengkun Yang, Wei Qin, Ketuan Huang & Tao Peng. (2018) The prognostic value of differentially expressed CYP3A subfamily members for hepatocellular carcinoma. Cancer Management and Research 10, pages 1713-1726.
Read now
Read now
Mariano A Giorgi, Guillermo Di Girolamo & Claudio D González. (2010) Nonresponders to clopidogrel: pharmacokinetics and interactions involved. Expert Opinion on Pharmacotherapy 11:14, pages 2391-2403.
Read now
Read now
Tao Zeng & Ke-Qin Xie. (2010) The Differential Modulation on Cytochrome P450 Enzymes by Garlic Components. Food Reviews International 26:4, pages 353-363.
Read now
Read now
Manisha Iyer, Erica J Reschly & Matthew D Krasowski. (2006) Functional evolution of the pregnane X receptor. Expert Opinion on Drug Metabolism & Toxicology 2:3, pages 381-397.
Read now
Read now
S. Ekins, A. Bugrim, L. Brovold, E. Kirillov, Y. Nikolsky, E. Rakhmatulin, S. Sorokina, A. Ryabov, T. Serebryiskaya, A. Melnikov, J. Metz & T. Nikolskaya. (2006) Algorithms for network analysis in systems-ADME/Tox using the MetaCore and MetaDrug platforms. Xenobiotica 36:10-11, pages 877-901.
Read now
Read now
Sean Ekins, Sergey Andreyev, Andy Ryabov, Eugene Kirillov, Eugene A Rakhmatulin, Andrej Bugrim & Tatiana Nikolskaya. (2005) Computational prediction of human drug metabolism. Expert Opinion on Drug Metabolism & Toxicology 1:2, pages 303-324.
Read now
Read now
Christopher H Hurst & David J Waxman. (2005) Interactions of Endocrine-active environmental chemicals with the nuclear receptor PXR. Toxicological & Environmental Chemistry 87:3, pages 299-311.
Read now
Read now
D. F. V. Lewis, B. G. Lake, M. Dickins & P. S. Goldfarb. (2004) Homology modelling of CYP3A4 from the CYP2C5 crystallographic template: analysis of typical CYP3A4 substrate interactions. Xenobiotica 34:6, pages 549-569.
Read now
Read now
Gary Ginsberg, Dale Hattis, Abel Russ & Babasaheb Sonawane. (2004) Physiologically Based Pharmacokinetic (PBPK) Modeling of Caffeine and Theophylline in Neonates and Adults: Implications for Assessing Children's Risks from Environmental Agents. Journal of Toxicology and Environmental Health, Part A 67:4, pages 297-329.
Read now
Read now
Ai‐Ming Yu, Jeffrey R. Idle & Frank J. Gonzalez. (2004) Polymorphic Cytochrome P450 2D6: Humanized Mouse Model and Endogenous Substrates. Drug Metabolism Reviews 36:2, pages 243-277.
Read now
Read now
Laurence H. Patterson. (2002) BIOREDUCTIVELY ACTIVATED ANTITUMOR N-OXIDES: THE CASE OF AQ4N, A UNIQUE APPROACH TO HYPOXIA-ACTIVATED CANCER CHEMOTHERAPY. Drug Metabolism Reviews 34:3, pages 581-592.
Read now
Read now
G. G. Gibson, N. J. Plant, K. E. Swales, A. Ayrton & W. El-Sankary. (2002) Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man. Xenobiotica 32:3, pages 165-206.
Read now
Read now
Michael B. Fisher, Mary F. Paine, Timothy J. Strelevitz & Steven A. Wrighton. (2001) The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*†. Drug Metabolism Reviews 33:3-4, pages 273-297.
Read now
Read now
Articles from other publishers (154)
Yanling Wu, Kun Li, Menglong Li, Xuemei Pu & Yanzhi Guo. (2023) Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy. Journal of Chemical Information and Modeling 63:22, pages 7011-7031.
Crossref
Crossref
Jung Sun Kim, Sunyoung Shim, Jeong Yee, Kyung Hee Choi & Hye Sun Gwak. (2023) Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis. Frontiers in Pharmacology 14.
Crossref
Crossref
Marilyn Silva & Ryan Kin‐Hin Kwok. (2022) Use of computational toxicology models to predict toxicological points of departure: A case study with triazine herbicides. Birth Defects Research 115:5, pages 525-544.
Crossref
Crossref
Fei Lin, Xinhua Lin, Xuewen Wang, Guanghui Mei, Bing Chen, Hong Yao & Lingyi Huang. (2023) Inhibitory effect of Selaginella doederleinii hieron on human cytochrome P450. Frontiers in Pharmacology 14.
Crossref
Crossref
Takashi Kondo, Ippei Suzuki, Tsuyoshi Chiba & Yuko Tousen. (2022) Safety assessment of herbal supplement components targeting hepatotoxicity and CYP3A4 induction in cell‐based assay using HepG2 cells. Journal of Food Science 88:1, pages 563-573.
Crossref
Crossref
Muhammad Asyraf Abduraman, Nor Hidayah Mustafa, Nik Soriani Yaacob, Azimah Amanah & Mei Lan Tan. (2022) Cytochrome P450 inhibition activities of non-standardized botanical products. Journal of Ethnopharmacology 296, pages 115406.
Crossref
Crossref
Shruti Koulgi, Vinod Jani, Samiron Phukan, Uddhavesh Sonavane, Rajendra Joshi, Rajender Kumar Kamboj & Venkata Palle. (2022) A Deep Dive into the Conformational Dynamics of CYP3A4 : Understanding the Binding of Homotropic and Non‐homotropic Ligands for Mitigating Drug‐Drug interaction (DDI). ChemistrySelect 7:17.
Crossref
Crossref
Li Jing, Yanmin Sun, Ji Wang, Xianqing Zhou & Zhixiong Shi. (2022) Oxidative stress and endoplasmic reticulum stress contributed to hepatotoxicity of decabromodiphenyl ethane (DBDPE) in L-02 cells. Chemosphere 286, pages 131550.
Crossref
Crossref
Usman Ali Ashfaq, Farah Shahid & Samman Munir. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
29
72
.
Christian Schulz, Friedrich Jung & Jan-Heiner Küpper. (2021) Inhibition of phase-1 biotransformation and cytostatic effects of diphenyleneiodonium on hepatoblastoma cell line HepG2 and a CYP3A4-overexpressing HepG2 cell clone. Clinical Hemorheology and Microcirculation 79:1, pages 231-243.
Crossref
Crossref
Tessa A. M. Mulder, Ruben A. G. van Eerden, Mirjam de With, Laure Elens, Dennis A. Hesselink, Maja Matic, Sander Bins, Ron H. J. Mathijssen & Ron H. N. van Schaik. (2021) CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?. Frontiers in Genetics 12.
Crossref
Crossref
Yoon-Jee Chae, Min-Soo Kim, Suk-Jae Chung, Mi-Kyung Lee, Kyeong-Ryoon Lee & Han-Joo Maeng. (2021) Pharmacokinetic Estimation Models-based Approach to Predict Clinical Implications for CYP Induction by Calcitriol in Human Cryopreserved Hepatocytes and HepaRG Cells. Pharmaceutics 13:2, pages 181.
Crossref
Crossref
Srinivas Banoth, Anjana Devi Tangutur, Archana Anthappagudem, Janaki Ramaiah & Bhima Bhukya. (2020) Cloning and in vivo metabolizing activity study of CYP3A4 on amiodarone drug residues: A possible probiotic and therapeutic option. Biomedicine & Pharmacotherapy 127, pages 110128.
Crossref
Crossref
Ana Martinho, Sara M. Silva, Tiago Rosado, Fernanda C. Domingues, Samuel Silvestre, Luiza Breitenfeld, Gilberto Alves, Ana P. Duarte & Eugenia Gallardo. (2020) Valeriana spp.: Biological Activities and New In vitro and In vivo Perspectives. Current Bioactive Compounds 16:3, pages 210-242.
Crossref
Crossref
Harutoshi Kato. (2020) Computational prediction of cytochrome P450 inhibition and induction. Drug Metabolism and Pharmacokinetics 35:1, pages 30-44.
Crossref
Crossref
Yohei Miyamoto, Takanori Oh, Eiji Aihara & Akihiro Ando. 2022. The Kappa Opioid Receptor. The Kappa Opioid Receptor
455
472
.
Maria Yousuf, Waqas Jamil & Khayala Mammadova. (2019) Microbial Bioconversion: A Regio-specific Method for Novel Drug Design and Toxicological Study of Metabolites. Current Pharmaceutical Biotechnology 20:14, pages 1156-1162.
Crossref
Crossref
Wenlong Wei, Haojv Li, Zhenwei Li, Hua Qu, Juan Da, Xu Jin, Yingying Wang, Wanying Wu & De-an Guo. (2019) Simultaneous determination of cinobufagin and its five metabolites in rat plasma by LC-MS/MS for characterization of metabolic profiles and pharmacokinetic study. Analytical Methods 11:42, pages 5464-5471.
Crossref
Crossref
Kiani, Ranaghan, Jabeen & Mulholland. (2019) Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors. International Journal of Molecular Sciences 20:18, pages 4468.
Crossref
Crossref
Lydia Benkaidali, François André, Gautier Moroy, Bahoueddine Tangour, François Maurel & Michel Petitjean. (2019) Four Major Channels Detected in the Cytochrome P450 3A4: A Step toward Understanding Its Multispecificity. International Journal of Molecular Sciences 20:4, pages 987.
Crossref
Crossref
Sarah Kammerer & Jan-Heiner Küpper. (2019) Optimized protocol for induction of cytochrome P450 enzymes 1A2 and 3A4 in human primary-like hepatocyte cell strain HepaFH3 to study in vitro toxicology. Clinical Hemorheology and Microcirculation 70:4, pages 563-571.
Crossref
Crossref
Yingdan Yuan, Maoyun Yu, Zhaohui Jia, Xue’er Song, Yingquan Liang & Jinchi Zhang. (2018) Analysis of Dendrobium huoshanense transcriptome unveils putative genes associated with active ingredients synthesis. BMC Genomics 19:1.
Crossref
Crossref
Dhwanil A. Dalwadi, Luis Ozuna, Brian H. Harvey, Michelle Viljoen & John A. Schetz. (2018) Adverse Neuropsychiatric Events and Recreational Use of Efavirenz and Other HIV-1 Antiretroviral Drugs. Pharmacological Reviews 70:3, pages 684-711.
Crossref
Crossref
Hongzhi Yu, Hongxia Shao, Qi Wu, Xin Sun, Li Li, Kuan Li, Xue Li, Yu Li, Qiuyang Zhang, Junping Wu & Huaiyong Chen. (2017) Altered gene expression of hepatic cytochrome P450 in a rat model of intermittent hypoxia with emphysema. Molecular Medicine Reports 16:1, pages 881-886.
Crossref
Crossref
Yin-Ming Kuo, Ryan A. Henry & Andrew J. Andrews. (2016) Measuring specificity in multi-substrate/product systems as a tool to investigate selectivity in vivo. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1864:1, pages 70-76.
Crossref
Crossref
Giordano Mancini & Costantino Zazza. (2015) F429 Regulation of Tunnels in Cytochrome P450 2B4: A Top Down Study of Multiple Molecular Dynamics Simulations. PLOS ONE 10:9, pages e0137075.
Crossref
Crossref
Tiong Chai Seah, Yea Lu Tay, Heng Kean Tan, Tengku Sifzizul Tengku Muhammad, Habibah Abdul Wahab & Mei Lan Tan. (2015) Determination of CYP3A4 Inducing Properties of Compounds Using a Laboratory-Developed Cell-Based Assay. International Journal of Toxicology 34:5, pages 454-468.
Crossref
Crossref
Diane Ramsden, Jin Zhou & Donald J. Tweedie. (2015) Determination of a Degradation Constant for CYP3A4 by Direct Suppression of mRNA in a Novel Human Hepatocyte Model, HepatoPac. Drug Metabolism and Disposition 43:9, pages 1307-1315.
Crossref
Crossref
N. Herzog, N. Katzenberger, F. Martin, K.-U. Schmidtke & J.-H. K. (2015) Generation of cytochrome P450 3A4-overexpressing HepG2 cell clones for standardization of hepatocellular testosterone 6β-hydroxylation activity. Journal of Cellular Biotechnology 1:1, pages 15-26.
Crossref
Crossref
Diane M. Calinski, Haoming Zhang, Susan Ludeman, M. Eileen Dolan & Paul F. Hollenberg. (2015)
Hydroxylation and
N-
Dechloroethylation of Ifosfamide and Deuterated Ifosfamide by the Human Cytochrome P450s and Their Commonly Occurring Polymorphisms
. Drug Metabolism and Disposition 43:7, pages 1084-1090.
Crossref
Crossref
Dany Spaggiari, Laurent Geiser, Youssef Daali & Serge Rudaz. (2014) A cocktail approach for assessing the in vitro activity of human cytochrome P450s: An overview of current methodologies. Journal of Pharmaceutical and Biomedical Analysis 101, pages 221-237.
Crossref
Crossref
Monimoy Banerjee & Taosheng Chen. (2014) Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1. Biochemical Pharmacology 92:2, pages 389-402.
Crossref
Crossref
Swati Nagar, Jeffrey P. Jones & Ken Korzekwa. (2014) A Numerical Method for Analysis of In Vitro Time-Dependent Inhibition Data. Part 1. Theoretical Considerations. Drug Metabolism and Disposition 42:9, pages 1575-1586.
Crossref
Crossref
Xue Fen Koe, Tengku Sifzizul Tengku Muhammad, Alexander Shu‐Chien Chong, Habibah Abdul Wahab & Mei Lan Tan. (2014)
Cytochrome P450 induction properties of food and herbal‐derived compounds using a novel multiplex RT‐
qPCR
in vitro assay, a drug–food interaction prediction tool
. Food Science & Nutrition 2:5, pages 500-520.
Crossref
Crossref
Seiji Hokimoto, Tadasuke Chitose, Michio Mizobe, Tomonori Akasaka, Yuichiro Arima, Koichi Kaikita, Satomi Iwashita, Kazunori Morita, Hiroko Miyazaki, Kentaro Oniki, Kunihiko Matsui, Kazuko Nakagawa & Hisao Ogawa. (2014) Impact of CYP3A5 polymorphism on platelet reactivity at percutaneous coronary intervention and after 9 months of aspirin and clopidogrel therapy in Japanese patients with coronary artery disease. European Journal of Clinical Pharmacology 70:6, pages 667-673.
Crossref
Crossref
Yongmei Li, Jin Zhou, Diane Ramsden, Mitchell E. Taub, Drané O'Brien, Jun Xu, Carl A. Busacca, Nina Gonnella & Donald J. Tweedie. (2014) Enzyme-Transporter Interplay in the Formation and Clearance of Abundant Metabolites of Faldaprevir Found in Excreta but not in Circulation. Drug Metabolism and Disposition 42:3, pages 384-393.
Crossref
Crossref
Rui Gu, David E. Hibbs, Jennifer A. Ong, Robert J. Edwards & Michael Murray. (2014) The multikinase inhibitor axitinib is a potent inhibitor of human CYP1A2. Biochemical Pharmacology 88:2, pages 245-252.
Crossref
Crossref
Lianhong Xu, Hongtao Liu, Allen Hong, Randy Vivian, Bernard P. Murray, Christian Callebaut, You-Chul Choi, Melody S. Lee, Jennifer Chau, Luong K. Tsai, Kirsten M. Stray, Robert G. Strickley, Jianhong Wang, Leah Tong, Swami Swaminathan, Gerry R. Rhodes & Manoj C. Desai. (2014) Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers. Part II: P2/P3 region and discovery of cobicistat (GS-9350). Bioorganic & Medicinal Chemistry Letters 24:3, pages 995-999.
Crossref
Crossref
Thundiparambil Azeez Sonia & Chandra P. Sharma. 2014. Oral Delivery of Insulin. Oral Delivery of Insulin
113
168
.
Eric F. Johnson, J. Patrick Connick, James R. Reed, Wayne L. Backes, Manoj C. Desai, Lianhong Xu, D. Fernando Estrada, Jennifer S. Laurence & Emily E. Scott. (2014) Correlating Structure and Function of Drug-Metabolizing Enzymes: Progress and Ongoing Challenges. Drug Metabolism and Disposition 42:1, pages 9-22.
Crossref
Crossref
Ernesto Callegari, Amit S. Kalgutkar, Louis Leung, R. Scott Obach, David R. Plowchalk & Susanna Tse. (2013) Drug Metabolites as Cytochrome P450 Inhibitors: A Retrospective Analysis and Proposed Algorithm for Evaluation of the Pharmacokinetic Interaction Potential of Metabolites in Drug Discovery and Development. Drug Metabolism and Disposition 41:12, pages 2047-2055.
Crossref
Crossref
Xue Fen Koe, Ee Lin Lim, Tiong Chai Seah, Azimah Amanah, Habibah Abdul Wahab, Mohd Ilham Adenan, Shaida Fariza Sulaiman & Mei Lan Tan. (2013) Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.. Food and Chemical Toxicology 60, pages 98-108.
Crossref
Crossref
Raj Vuppalanchi, Tiebing Liang, Chirayu Pankaj Goswami, Rohit Nalamasu, Lang Li, David Jones, Rongrong Wei, Wanqing Liu, Vishal Sarasani, Sarath Chandra Janga & Naga Chalasani. (2013) Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis. PLoS ONE 8:9, pages e74471.
Crossref
Crossref
Rong Zhang, Sui-Qing Mi & Ning-Sheng Wang. (2013) Effect of borneol on cytochrome P450 3A enzyme and midazolam pharmacokinetics in rats. European Journal of Drug Metabolism and Pharmacokinetics 38:3, pages 159-169.
Crossref
Crossref
Javier L. Baylon, Ivan L. Lenov, Stephen G. Sligar & Emad Tajkhorshid. (2013) Characterizing the Membrane-Bound State of Cytochrome P450 3A4: Structure, Depth of Insertion, and Orientation. Journal of the American Chemical Society 135:23, pages 8542-8551.
Crossref
Crossref
Lianhong Xu & Manoj C. Desai. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
451
481
.
ENQI QIAO, MINGHUA JI, JIANZHONG WU, RONG MA, XIAOHUA ZHANG, YUEJUN HE, QUANBIN ZHA, XUE SONG, LI-WEI ZHU & JINHAI TANG. (2013) Expression of the PXR gene in various types of cancer and drug resistance. Oncology Letters 5:4, pages 1093-1100.
Crossref
Crossref
Ee Lin Lim, Tiong Chai Seah, Xue Fen Koe, Habibah Abdul Wahab, Mohd Ilham Adenan, Mohd Fadzly Amar Jamil, Mohamed Isa Abdul Majid & Mei Lan Tan. (2013) In vitro evaluation of cytochrome P450 induction and the inhibition potential of mitragynine, a stimulant alkaloid. Toxicology in Vitro 27:2, pages 812-824.
Crossref
Crossref
Nilufer Rahmioglu, James Heaton, Gail Clement, Raj Gill, Gabriela Surdulescu, Karolina Zlobecka, Dylan Hodgkiss, Norman W. Smith & Kourosh R. Ahmadi. (2012) Genome-wide association study reveals a complex genetic architecture underpinning-induced CYP3A4 enzyme activity. European Journal of Drug Metabolism and Pharmacokinetics 38:1, pages 63-67.
Crossref
Crossref
Arti Mathur, Donald J. Tweedie, Holly Hlaing-Hlaing Maw & Yongmei Li. (2013) Unexpected interaction between CYP3A4 and BI 11634: is BI 11634 interacting with CYP3A4 similar to nifedipine?. Drug Metabolism and Drug Interactions 28:4.
Crossref
Crossref
Amitava Dasgupta. 2012. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring. Resolving Erroneous Reports in Toxicology and Therapeutic Drug Monitoring
355
384
.
Akihiro Ando, Keiyu Oshida, Shinichi Fukuyama, Ayano Watanabe, Hisashi Hashimoto & Yohei Miyamoto. (2012) Identification of human cytochrome P450 enzymes involved in the metabolism of a novel к‐opioid receptor agonist, nalfurafine hydrochloride. Biopharmaceutics & Drug Disposition 33:5, pages 257-264.
Crossref
Crossref
Cindy Bandala, E. Floriano-Sanchez, N. Cardenas-Rodriguez, J. Lopez-Cruz & E. Lara-Padilla. (2012) RNA Expression of Cytochrome P450 in Mexican Women with Breast Cancer. Asian Pacific Journal of Cancer Prevention 13:6, pages 2647-2653.
Crossref
Crossref
Kai‐Ming Duan, Sai‐Ying Wang, Wen Ouyang, Yan‐Mei Mao & Li‐Jun Yang. (2013) Effect of Quercetin on CYP3A Activity in Chinese Healthy Participants. The Journal of Clinical Pharmacology 52:6, pages 940-946.
Crossref
Crossref
Kathrin Klein, Maria Thomas, Stefan Winter, Andreas K. Nussler, Mikko Niemi, Matthias Schwab & Ulrich M. Zanger. (2012) PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo. Clinical Pharmacology & Therapeutics 91:6, pages 1044-1052.
Crossref
Crossref
Ulrich M. Zanger, Kathrin Klein & Jessica Rieger. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
259
284
.
Trisha L. Noreault-Conti, Abigail Fellows, Judith M. Jacobs, Heidi W. Trask, Stephen C. Strom, Ronald M. Evans, Steven A. Wrighton, Peter R. Sinclair, Jacqueline F. Sinclair & Ralph C. Nichols. (2012) Arsenic decreases RXRα-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes. International Immunopharmacology 12:4, pages 651-656.
Crossref
Crossref
Yakun Chen, Yong Tang, Changxiong Guo, Jiuhui Wang, Debasish Boral & Daotai Nie. (2012) Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochemical Pharmacology 83:8, pages 1112-1126.
Crossref
Crossref
Joo Yun Lee, Nam Sook Kang & Young Kee Kang. (2012) Binding free energies of inhibitors to iron porphyrin complex as a model for Cytochrome P450. Biopolymers 97:4, pages 219-228.
Crossref
Crossref
Irina F. Sevrioukova & Thomas L. Poulos. (2012) Structural and Mechanistic Insights into the Interaction of Cytochrome P4503A4 with Bromoergocryptine, a Type I Ligand. Journal of Biological Chemistry 287:5, pages 3510-3517.
Crossref
Crossref
Bo Jiang, Fei Cai, Shouhong Gao, Liyuan Meng, Fengying Liang, Xiao Dai, Wen Xu & Wansheng Chen. (2012) Induction of cytochrome P450 3A by Shexiang Baoxin Pill and its main components. Chemico-Biological Interactions 195:2, pages 105-113.
Crossref
Crossref
Ji-Hong Shon, Hei-Young Ku, Seol-Youn Bae, Min-Kyung Oh, Chang-Woo Yeo, Soo-Kyung Bae & Jae-Gook Shin. (2011) The disposition of three phosphodiesterase type 5 inhibitors, vardenafil, sildenafil, and udenafil, is differently influenced by the CYP3A5 genotype. Pharmacogenetics and Genomics 21:12, pages 820-828.
Crossref
Crossref
Raj Vuppalanchi, Ravi Juluri, Marwan Ghabril, Seongho Kim, Nancy Thong, Jude Christopher Gorski, Naga Chalasani & Stephen D. Hall. (2011) Drug-induced QT Prolongation in Cirrhotic Patients With Transjugular Intrahepatic Portosystemic Shunt. Journal of Clinical Gastroenterology 45:7, pages 638-642.
Crossref
Crossref
Xiao-Long Hou, Emi Hayashi-Nakamura, Tomoka Takatani-Nakase, Ken Tanaka, Kyoko Takahashi, Katsuko Komatsu & Koichi Takahashi. (2011)
Curdione Plays an Important Role in the Inhibitory Effect of
Curcuma aromatica
on CYP3A4 in Caco-2 Cells
. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-9.
Crossref
Crossref
Matthew D. Krasowski & John L. Blau. 2010. Herbal Supplements. Herbal Supplements
273
290
.
Nagendra Kumar Chaturvedi, Sanjay Kumar, Seema Negi & Rakesh K. Tyagi. (2010) Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders. Molecular and Cellular Biochemistry 345:1-2, pages 291-308.
Crossref
Crossref
Donald J. AbrahamAnke‐Hilse Maitland‐van der Zee, Brian J. Puckett, Steven G. Terra & Joe Walker. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
181
204
.
Amin A. Nomeir. 2010. Early Drug Development. Early Drug Development
25
88
.
Dan FishelovitchSason ShaikHaim J. WolfsonRuth Nussinov. (2010) How Does the Reductase Help To Regulate the Catalytic Cycle of Cytochrome P450 3A4 Using the Conserved Water Channel?. The Journal of Physical Chemistry B 114:17, pages 5964-5970.
Crossref
Crossref
Michael ZientekChad StonerRobyn AyscueJacquelyn Klug-McLeodYing JiangMichael WestClaire CollinsSean Ekins. (2010) Integrated in Silico−in Vitro Strategy for Addressing Cytochrome P450 3A4 Time-Dependent Inhibition. Chemical Research in Toxicology 23:3, pages 664-676.
Crossref
Crossref
Ioannis S. Vizirianakis. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
28
.
Arabelle Pfrunder, Heike Gutmann, Christoph Beglinger & Jürgen Drewe. (2003) Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines. Journal of Pharmacy and Pharmacology 55:1, pages 59-66.
Crossref
Crossref
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
55
107
.
R. Scott Obach. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
241
264
.
Tao Zeng, Cui-Li Zhang, Fu-Yong Song, Xiao-Ying Han & Ke-Qin Xie. (2009) The modulatory effects of garlic oil on hepatic cytochrome P450s in mice. Human & Experimental Toxicology 28:12, pages 777-783.
Crossref
Crossref
Inhou Chu. 2009. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition. Using Mass Spectrometry for Drug Metabolism Studies, Second Edition
99
126
.
Beatrice Oneda, Severine Crettol, Evelyne Jaquenoud Sirot, Murielle Bochud, Nicolas Ansermot & Chin B. Eap. (2009) The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test. Pharmacogenetics and Genomics 19:11, pages 877-883.
Crossref
Crossref
Dan FishelovitchSason ShaikHaim J. WolfsonRuth Nussinov. (2009) Theoretical Characterization of Substrate Access/Exit Channels in the Human Cytochrome P450 3A4 Enzyme: Involvement of Phenylalanine Residues in the Gating Mechanism. The Journal of Physical Chemistry B 113:39, pages 13018-13025.
Crossref
Crossref
Marcel J. de Groot, Florian Wakenhut, Gavin Whitlock & Ruth Hyland. (2009) Understanding CYP2D6 interactions. Drug Discovery Today 14:19-20, pages 964-972.
Crossref
Crossref
Ruth Hyland, R. Scott Obach, Chad Stoner, Michael West, Michael R. Wester, Kuresh Youdim & Michael Zientek. 2009. Hit and Lead Profiling. Hit and Lead Profiling
165
196
.
Nada Božina, Vlasta Bradamante & Mila Lovrić. (2009) Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk. Archives of Industrial Hygiene and Toxicology 60:2, pages 217-242.
Crossref
Crossref
Gabriela Mustata, Ariele Viacava Follis, Dalia I. Hammoudeh, Steven J. Metallo, Huabo Wang, Edward V. Prochownik, John S. Lazo & Ivet Bahar. (2009) Discovery of Novel Myc−Max Heterodimer Disruptors with a Three-Dimensional Pharmacophore Model. Journal of Medicinal Chemistry 52:5, pages 1247-1250.
Crossref
Crossref
Changcheng Zhou, Suman Verma & Bruce Blumberg. (2009) The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism. Nuclear Receptor Signaling 7:1, pages nrs.07001.
Crossref
Crossref
Kenneth Bachmann. 2009. Pharmacology. Pharmacology
303
325
.
Chitra Sridar, Ute M. Kent, Kate Noon, Alecia McCall, Bill Alworth, Maryam Foroozesh & Paul F. Hollenberg. (2008) Differential Inhibition of Cytochromes P450 3A4 and 3A5 by the Newly Synthesized Coumarin Derivatives 7-Coumarin Propargyl Ether and 7-(4-Trifluoromethyl)coumarin Propargyl Ether. Drug Metabolism and Disposition 36:11, pages 2234-2243.
Crossref
Crossref
Eitan Yaffe, Dan Fishelovitch, Haim J. Wolfson, Dan Halperin & Ruth Nussinov. (2008) MolAxis: Efficient and accurate identification of channels in macromolecules. Proteins: Structure, Function, and Bioinformatics 73:1, pages 72-86.
Crossref
Crossref
J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin Otto Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith J. Johnson, David A. Katz, Mark N. Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Subrahmanyam Vangala & Steven A. Wrighton. (2008) PhRMA White Paper on ADME Pharmacogenomics. The Journal of Clinical Pharmacology 48:7, pages 849-889.
Crossref
Crossref
C.L. Dalla Corte, R. Fachinetto, D. Colle, R.P. Pereira, D.S. Ávila, J.G. Villarinho, C. Wagner, M.E. Pereira, C.W. Nogueira, F.A.A. Soares & J.B.T. Rocha. (2008) Potentially adverse interactions between haloperidol and valerian. Food and Chemical Toxicology 46:7, pages 2369-2375.
Crossref
Crossref
Yasuhiro Imaeda, Takanobu Kuroita, Hiroki Sakamoto, Tetsuji Kawamoto, Mamoru Tobisu, Noriko Konishi, Katsuhiko Hiroe, Masaki Kawamura, Toshimasa Tanaka & Keiji Kubo. (2008)
Discovery of Imidazo[1,5-
c
]imidazol-3-ones: Weakly Basic, Orally Active Factor Xa Inhibitors
. Journal of Medicinal Chemistry 51:12, pages 3422-3436.
Crossref
Crossref
Yasuhiro Imaeda, Toshio Miyawaki, Hiroki Sakamoto, Fumio Itoh, Noriko Konishi, Katsuhiko Hiroe, Masaki Kawamura, Toshimasa Tanaka & Keiji Kubo. (2008) Discovery of sulfonylalkylamides: A new class of orally active factor Xa inhibitors. Bioorganic & Medicinal Chemistry 16:5, pages 2243-2260.
Crossref
Crossref
Yojiro Sakiyama, Hitomi Yuki, Takashi Moriya, Kazunari Hattori, Misaki Suzuki, Kaoru Shimada & Teruki Honma. (2008) Predicting human liver microsomal stability with machine learning techniques. Journal of Molecular Graphics and Modelling 26:6, pages 907-915.
Crossref
Crossref
Dan FishelovitchCarina HazanHajime HiraoHaim J. WolfsonRuth NussinovSason Shaik. (2007) QM/MM Study of the Active Species of the Human Cytochrome P450 3A4, and the Influence Thereof of the Multiple Substrate Binding. The Journal of Physical Chemistry B 111:49, pages 13822-13832.
Crossref
Crossref
David R. Jones, Sean Ekins, Lang Li & Stephen D. Hall. (2007)
Computational Approaches That Predict Metabolic Intermediate Complex Formation with CYP3A4 (+
b
5
)
. Drug Metabolism and Disposition 35:9, pages 1466-1475.
Crossref
Crossref
Robert P. Sheridan, Kenneth R. Korzekwa, Rhonda A. Torres & Matthew J. Walker. (2007) Empirical Regioselectivity Models for Human Cytochromes P450 3A4, 2D6, and 2C9. Journal of Medicinal Chemistry 50:14, pages 3173-3184.
Crossref
Crossref
Xiao-Long Hou, Kyoko Takahashi, Natsumi Kinoshita, Feng Qiu, Ken Tanaka, Katsuko Komatsu, Koichi Takahashi & Junichi Azuma. (2007) Possible inhibitory mechanism of Curcuma drugs on CYP3A4 in 1α,25 dihydroxyvitamin D3 treated Caco-2 cells. International Journal of Pharmaceutics 337:1-2, pages 169-177.
Crossref
Crossref
Hongjian Zhang, Donglu Zhang, Wenying Li, Ming Yao, Celia D'Arienzo, Yi-Xin Li, William R. Ewing, Zhengxiang Gu, Yeheng Zhu, Natesan Murugesan, Wen-Chyi Shyu & W. Griffith Humphreys. (2007) Reduction of Site-Specific CYP3A-Mediated Metabolism for Dual Angiotensin and Endothelin Receptor Antagonists in Various in Vitro Systems and in Cynomolgus Monkeys. Drug Metabolism and Disposition 35:5, pages 795-805.
Crossref
Crossref
H. J. Peter de Lijser, Natalie Ann Rangel, Michelle A. Tetalman & Chao-Kuan Tsai. (2007) Mechanistic Aspects of the Formation of Aldehydes and Nitriles in Photosensitized Reactions of Aldoxime Ethers. The Journal of Organic Chemistry 72:11, pages 4126-4134.
Crossref
Crossref
Yuan Yao, Wei-wei Han, Yi-han Zhou, Ze-sheng Li, Qiang Li, Xiao-yan Li, Xiao-yan Chen & Da-fang Zhong. (2007) The inhibition effect of 20(S)-Protopanaxadiol (PPD) and Ginsenoside Rh2 for CYP2C9 and CYP3A4. Polymer 48:9, pages 2644-2648.
Crossref
Crossref
E. Vaccaro, A. Salvetti, R. Del Carratore, S. Nencioni, V. Longo & P. G. Gervasi. (2007)
Cloning, tissue expression, and inducibility of CYP 3A79 from sea bass (
Dicentrarchus labrax
)
. Journal of Biochemical and Molecular Toxicology 21:1, pages 32-40.
Crossref
Crossref
Edith J. Mensah‐Osman, Dafydd G. Thomas, Michelle M. Tabb, Jose M. Larios, Dennis P. Hughes, Thomas J. Giordano, Michelle L. Lizyness, James M. Rae, Bruce Blumberg, Paul F. Hollenberg & Laurence H. Baker. (2007) Expression levels and activation of a PXR variant are directly related to drug resistance in osteosarcoma cell lines. Cancer 109:5, pages 957-965.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2007) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 4:3, pages 257-405.
Crossref
Crossref
Berith F. Jensen, Christian Vind, Søren B. Padkjær, Per B. Brockhoff & Hanne H. F. Refsgaard. (2007)
In Silico Prediction of Cytochrome P450 2D6 and 3A4 Inhibition Using Gaussian Kernel Weighted
k
-Nearest Neighbor and Extended Connectivity Fingerprints, Including Structural Fragment Analysis of Inhibitors versus Noninhibitors
. Journal of Medicinal Chemistry 50:3, pages 501-511.
Crossref
Crossref
Dan FishelovitchCarina HazanSason ShaikHaim J. WolfsonRuth Nussinov. (2007) Structural Dynamics of the Cooperative Binding of Organic Molecules in the Human Cytochrome P450 3A4. Journal of the American Chemical Society 129:6, pages 1602-1611.
Crossref
Crossref
Sayeepriyadarshini Anakk, Wendong Huang, Jeffrey L. Staudinger, Kheng Tan, Timothy J. Cole, David D. Moore & Henry W. Strobel. (2007) Gender Dictates the Nuclear Receptor-Mediated Regulation of CYP3A44. Drug Metabolism and Disposition 35:1, pages 36-42.
Crossref
Crossref
Thomas Fox & Jan M. Kriegl. 2007.
63
81
.
Larry J. Jolivette & Sean Ekins. 2007.
131
176
.
Sanjay Yadav, Alok Dhawan, Prahlad K. Seth, Ram L. Singh & Devendra Parmar. (2006) Cytochrome P4503A: Evidence for mRNA expression and catalytic activity in rat brain. Molecular and Cellular Biochemistry 287:1-2, pages 91-99.
Crossref
Crossref
Ping He, Michael H. Court, David J. Greenblatt & Lisa L. von Moltke. (2006) FACTORS INFLUENCING MIDAZOLAM HYDROXYLATION ACTIVITY IN HUMAN LIVER MICROSOMES. Drug Metabolism and Disposition 34:7, pages 1198-1207.
Crossref
Crossref
Daniel D. Holsworth, Cuiman Cai, Xue-Min Cheng, Wayne L. Cody, Dennis M. Downing, Noe Erasga, Chitase Lee, Noel A. Powell, Jeremy J. Edmunds, Michael Stier, Mehran Jalaie, Erli Zhang, Pat McConnell, Michael J. Ryan, John Bryant, Tingsheng Li, Aparna Kasani, Eric Hall, Rajendra Subedi, Mohammad Rahim & Samarendra Maiti. (2006) Ketopiperazine-based renin inhibitors: Optimization of the “C” ring. Bioorganic & Medicinal Chemistry Letters 16:9, pages 2500-2504.
Crossref
Crossref
Dimitrios T.P. Trafalis, George D. Geromichalos, Catherine Koukoulitsa, Athanasios Papageorgiou, Panayiotis Karamanakos & and Charalambos Camoutsis. (2005) Lactandrate: a D-homo-aza-androsterone alkylator in the treatment of breast cancer. Breast Cancer Research and Treatment 97:1.
Crossref
Crossref
Sonja Krösser, Roland Neugebauer, Hugues Dolgos, Markus Fluck, Karl-Ludwig Rost & Andreas Kovar. (2006) Investigation of sarizotan’s impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trial. European Journal of Clinical Pharmacology 62:4, pages 277-284.
Crossref
Crossref
Tsutomu Shimada. (2006) Xenobiotic-Metabolizing Enzymes Involved in Activation and Detoxification of Carcinogenic Polycyclic Aromatic Hydrocarbons. Drug Metabolism and Pharmacokinetics 21:4, pages 257-276.
Crossref
Crossref
Joseph D. Ma, Anne N. Nafziger, Gerry Rhodes, Siyu Liu, Anne M. Gartung & Joseph S. BertinoJrJr. (2006) The Effect of Oral Pleconaril on Hepatic Cytochrome P450 3A Activity in Healthy Adults Using Intravenous Midazolam as a Probe. The Journal of Clinical Pharmacology 46:1, pages 103-108.
Crossref
Crossref
Yang Xu, Takanori Hashizume, Margaret C. Shuhart, Connie L. Davis, Wendel L. Nelson, Toshiyuki Sakaki, Thomas F. Kalhorn, Paul B. Watkins, Erin G. Schuetz & Kenneth E. Thummel. (2006)
Intestinal and Hepatic CYP3A4 Catalyze Hydroxylation of 1α,25-Dihydroxyvitamin D
3
: Implications for Drug-Induced Osteomalacia
. Molecular Pharmacology 69:1, pages 56-65.
Crossref
Crossref
R. Scott Obach, Robert L. Walsky, Karthik Venkatakrishnan, Emily A. Gaman, J. Brian Houston & Larry M. Tremaine. (2006) The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions. Journal of Pharmacology and Experimental Therapeutics 316:1, pages 336-348.
Crossref
Crossref
Andreas Verras, Irwin D. Kuntz & Paul R. Ortiz de Montellano. 2006.
171
195
.
Trisha L. Noreault, Judith M. Jacobs, Ralph C. Nichols, Heidi W. Trask, Steven A. Wrighton, Peter R. Sinclair, Ronald M. Evans & Jacqueline F. Sinclair. (2005) Arsenite decreases CYP3A23 induction in cultured rat hepatocytes by transcriptional and translational mechanisms. Toxicology and Applied Pharmacology 209:2, pages 174-182.
Crossref
Crossref
Jian-Ping Wang, De-Xiang Xu, Mei-Fang Sun, Yuan-Hua Chen, Hua Wang & Wei Wei. (2005) Chronic ethanol exposure downregulates hepatic expression of pregnane X receptor and P450 3A11 in female ICR mice. Toxicology 215:3, pages 234-244.
Crossref
Crossref
Evan D. Kharasch, Alysa Walker, Christine Hoffer & Pamela Sheffels. (2005) Sensitivity of Intravenous and Oral Alfentanil and Pupillary Miosis as Minimally Invasive and Noninvasive Probes for Hepatic and First-Pass CYP3A Activity. The Journal of Clinical Pharmacology 45:10, pages 1187-1197.
Crossref
Crossref
Hwangseo Park, Sangyoub Lee & Junghun Suh. (2005) Structural and Dynamical Basis of Broad Substrate Specificity, Catalytic Mechanism, and Inhibition of Cytochrome P450 3A4. Journal of the American Chemical Society 127:39, pages 13634-13642.
Crossref
Crossref
Haibo Xu, Ratheishan Rajesan, Patricia Harper, Richard B Kim, Bo Lonnerdal, Mingdong Yang, Satoko Uematsu, Janine Hutson, Jo Watson-MacDonell & Shinya Ito. (2005) Induction of cytochrome P450 1A by cow milk-based formula: a comparative study between human milk and formula. British Journal of Pharmacology 146:2, pages 296-305.
Crossref
Crossref
Trisha L. Noreault, Judith M. Jacobs, Ralph C. Nichols, Heidi W. Trask, Steven A. Wrighton, Peter R. Sinclair & Jacqueline F. Sinclair. (2005) Mechanism of arsenite-mediated decreases in CYP3A23 in rat hepatocytes. Biochemical and Biophysical Research Communications 333:4, pages 1211-1217.
Crossref
Crossref
Kenneth A Bachmann & Jeffrey D Lewis. (2017) Predicting Inhibitory Drug—Drug Interactions and Evaluating Drug Interaction Reports Using Inhibition Constants. Annals of Pharmacotherapy 39:6, pages 1064-1072.
Crossref
Crossref
Ying-Hong Wang, David R. Jones & Stephen D. Hall. (2005) DIFFERENTIAL MECHANISM-BASED INHIBITION OF CYP3A4 AND CYP3A5 BY VERAPAMIL. Drug Metabolism and Disposition 33:5, pages 664-671.
Crossref
Crossref
Rieko Arimoto, Madhu-Ashni Prasad & Eric M. Gifford. (2005) Development of CYP3A4 Inhibition Models: Comparisons of Machine-Learning Techniques and Molecular Descriptors. SLAS Discovery 10:3, pages 197-205.
Crossref
Crossref
Jan M. Kriegl, Lennart Eriksson, Thomas Arnhold, Bernd Beck, Erik Johansson & Thomas Fox. (2005) Multivariate modeling of cytochrome P450 3A4 inhibition. European Journal of Pharmaceutical Sciences 24:5, pages 451-463.
Crossref
Crossref
Jan M. Kriegl, Thomas Arnhold, Bernd Beck & Thomas Fox. (2005) A support vector machine approach to classify human cytochrome P450 3A4 inhibitors. Journal of Computer-Aided Molecular Design 19:3, pages 189-201.
Crossref
Crossref
Evan D. Kharasch, Alysa Walker, Christine Hoffer & Pamela Sheffels. (2005) Evaluation of First-Pass Cytochrome P4503A (CYP3A) and P-Glycoprotein Activities Using Alfentanil and Fexofenadine in Combination. The Journal of Clinical Pharmacology 45:1, pages 79-88.
Crossref
Crossref
Frank J. Gonzalez. (2005) Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 569:1-2, pages 101-110.
Crossref
Crossref
Miia Turpeinen, Uusitalo Jouko, Jalonen Jorma & Pelkonen Olavi. (2005) Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay. European Journal of Pharmaceutical Sciences 24:1, pages 123-132.
Crossref
Crossref
Evan D. Kharasch, Dale Whittington & Christine Hoffer. (2004) Influence of Hepatic and Intestinal Cytochrome P4503A Activity on the Acute Disposition and Effects of Oral Transmucosal Fentanyl Citrate. Anesthesiology 101:3, pages 729-737.
Crossref
Crossref
Luisella A Vignati, Alessia Bogni, Pietro Grossi & Mario Monshouwer. (2004) A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction. Toxicology 199:1, pages 23-33.
Crossref
Crossref
Michael Hall, Stefano Persiani, Yen‐Ling Cheung, Anne Matthews, Z. Richard Cybulski, Jeremy D. Holding, Ram Kapil, Massimo D'Amato, Francesco Makovec & Lucio C. Rovati. (2004) Interaction of dexloxiglumide, a cholecystokinin type‐1 receptor antagonist, with human cytochromes P450. Biopharmaceutics & Drug Disposition 25:4, pages 163-176.
Crossref
Crossref
Hong-Guang Xie, Alastair JJ Wood, Richard B Kim, C Michael Stein & Grant R Wilkinson. (2004) Genetic variability in CYP3A5 and its possible consequences. Pharmacogenomics 5:3, pages 243-272.
Crossref
Crossref
S Anakk, A Kalsotra, Y Kikuta, W Huang, J Zhang, J L Staudinger, D D Moore & H W Strobel. (2004) CAR/PXR provide directives for Cyp3a41 gene regulation differently from Cyp3a11. The Pharmacogenomics Journal 4:2, pages 91-101.
Crossref
Crossref
Hideko Kanazawa, Akiko Okada, Eri Igarashi, Megumu Higaki, Takako Miyabe, Tadashi Sano & Ryouhei Nishimura. (2004) Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography–mass spectrometry. Journal of Chromatography A 1031:1-2, pages 213-218.
Crossref
Crossref
Sean Ekins. (2004) Predicting undesirable drug interactions with promiscuous proteins in silico. Drug Discovery Today 9:6, pages 276-285.
Crossref
Crossref
Shiew-Mei Huang. 2004. Applications of Pharmacokinetic Principles in Drug Development. Applications of Pharmacokinetic Principles in Drug Development
307
331
.
Jeffrey C. Stevens, Ronald N. Hines, Chungang Gu, Sevasti B. Koukouritaki, Jason R. Manro, Peter J. Tandler & Matthew J. Zaya. (2003) Developmental Expression of the Major Human Hepatic CYP3A Enzymes. Journal of Pharmacology and Experimental Therapeutics 307:2, pages 573-582.
Crossref
Crossref
Kenneth Bachmann, Steven Wrighton & Barbara Ring. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
311
336
.
E Rouits, M Boisdron-Celle, A Morel & E Gamelin. (2003) Simple and sensitive high-performance liquid chromatography method for simultaneous determination of urinary free cortisol and 6β-hydroxycortisol in routine practice. Journal of Chromatography B 793:2, pages 357-366.
Crossref
Crossref
Srikanth C. Nallani, Bryan Goodwin, Jodi M. Maglich, Donna J. Buckley, Arthur R. Buckley & Pankaj B. Desai. (2003) Induction of Cytochrome P450 3A by Paclitaxel in Mice: Pivotal Role of the Nuclear Xenobiotic Receptor, Pregnane X Receptor. Drug Metabolism and Disposition 31:5, pages 681-684.
Crossref
Crossref
Camille P. Granvil, Ai-Ming Yu, Guillermo Elizondo, Taro E. Akiyama, Connie Cheung, Lionel Feigenbaum, Kristopher W. Krausz & Frank J. Gonzalez. (2003)
Expression of the Human
CYP3A4
Gene in the Small Intestine of Transgenic Mice: In Vitro Metabolism and Pharmacokinetics of Midazolam
. Drug Metabolism and Disposition 31:5, pages 548-558.
Crossref
Crossref
Judy L. Raucy. (2003) Regulation of CYP3A4 Expression in Human Hepatocytes by Pharmaceuticals and Natural Products. Drug Metabolism and Disposition 31:5, pages 533-539.
Crossref
Crossref
Sean Ekins, David M. Stresser & J. Andrew Williams. (2003) In vitro and pharmacophore insights into CYP3A enzymes. Trends in Pharmacological Sciences 24:4, pages 161-166.
Crossref
Crossref
How Sung Lee, Boon Cher Goh, Lu Fan, Yok Moi Khoo, Lingzhi Wang, Robert Lim, Ai Bee Ong & Charlotte Chua. (2003) Phenotyping CYP3A using midazolam in cancer and noncancer Asian patients. British Journal of Clinical Pharmacology 55:3, pages 270-277.
Crossref
Crossref
Donald J. AbrahamBrian J. Puckett, Steven G. Terra & Joe Walker. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
607
639
.
Steven A. Kliewer, Bryan Goodwin & Timothy M. Willson. (2002) The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism. Endocrine Reviews 23:5, pages 687-702.
Crossref
Crossref
J. Raucy. (2002) A Cell-Based Reporter Gene Assay for Determining Induction of CYP3A4 in a High-Volume System. Journal of Pharmacology and Experimental Therapeutics 303:1, pages 412-423.
Crossref
Crossref
Yukiko Akazawa, Hiroko Kawaguchi, Maki Funahashi, Yoshihiko Watanabe, Kiyoshi Yamaoka, Mitsuru Hashida & Yoshinobu Takakura. (2002) Effect of Interferons on P‐Glycoprotein‐Mediated Rhodamine‐123 Efflux in Cultured Rat Hepatocytes. Journal of Pharmaceutical Sciences 91:10, pages 2110-2115.
Crossref
Crossref
Vikram Arora, Melissa L. Cate, Chandramallika Ghosh & Patrick L. Iversen. (2002) Phosphorodiamidate Morpholino Antisense Oligomers Inhibit Expression of Human Cytochrome P450 3A4 and Alter Selected Drug Metabolism. Drug Metabolism and Disposition 30:7, pages 757-762.
Crossref
Crossref
Ioannis S. Vizirianakis. (2002) Pharmaceutical education in the wake of genomic technologies for drug development and personalized medicine. European Journal of Pharmaceutical Sciences 15:3, pages 243-250.
Crossref
Crossref
Peter Hlavica & David F. V. Lewis. (2008) Allosteric phenomena in cytochrome P450‐catalyzed monooxygenations. European Journal of Biochemistry 268:18, pages 4817-4832.
Crossref
Crossref
Gondi N. Kumar & Sekhar Surapaneni. (2001) Role of drug metabolism in drug discovery and development. Medicinal Research Reviews 21:5, pages 397-411.
Crossref
Crossref